SN6 Stolt-Nielsen Ltd.

Stolt Tankers to purchase five chemical tankers from CTG

Stolt Tankers to purchase five chemical tankers from CTG

LONDON, August 31, 2020 - Stolt-Nielsen Limited (Oslo Børs: SNI) announced today that Stolt Tankers B.V. has agreed to acquire five chemical tankers from Chemical Transportation Group (CTG) for trading in the Stolt Tankers Joint Service.  The five ships, which are 26,000 dwt and with stainless steel cargo sections, were built in China in 2016 and 2017.  The purchase of each ship is expected to close between December 2020 and February 2021. Further terms of the transaction were not disclosed.

Commenting on the purchase, Stolt Tankers President, Lucas Vos, said “This acquisition is an excellent opportunity for Stolt Tankers to replace ships being retired in the next few years, lowering our fleet age profile with competitively priced ships that can trade in any of our deep-sea lanes.  Newer, fuel-efficient ships help us reduce our carbon footprint while buying existing tonnage means capacity is not added to a market that doesn’t need it.  In a cyclical industry like ours, buying the right ships at the right price is the path to financial sustainability.  In the end, Stolt Tankers’ customers are the real winners in this deal, as these ships will support our proven platform that provides a high quality, reliable and flexible service offering.”

For additional information please contact:

Jens F. Grüner-Hegge

Chief Financial Officer

UK +44 (0) 20 7611 8985

Ellie Davison

Head of Corporate Communications

UK +44 (0) 20 7611 8926

About Stolt-Nielsen Limited

Stolt-Nielsen (SNL or the ‘Company’)  is a long-term investor and manager of businesses focused on opportunities in logistics, distribution and aquaculture. The Stolt-Nielsen portfolio consists of its three global bulk-liquid and chemicals logistics businesses – Stolt Tankers, Stolthaven Terminals and Stolt Tank Containers – Stolt Sea Farm and a number of LNG investments. Stolt-Nielsen Limited is listed on the Oslo Stock Exchange (Oslo Børs: SNI).

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

EN
31/08/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Stolt-Nielsen Ltd.

 PRESS RELEASE

Stolt-Nielsen Limited: Fixed Income Investor Meetings

Stolt-Nielsen Limited: Fixed Income Investor Meetings LONDON October 6, 2025 - Stolt-Nielsen Limited (Oslo Børs: SNI) has mandated Danske Bank, DNB Carnegie, Fearnley Securities and Nordea to arrange a series of fixed income investor meetings commencing today, October 6, 2025. Following the investor meetings a NOK denominated five-year senior unsecured bond issue may follow, subject to inter alia market conditions. The proceeds from the potential bond issue will be used for general corporate purposes. For additional information please contact: Jens F. Grüner-Hegge Chief Financial Offic...

ABGSC Shipping & Transport Research ... (+3)
  • ABGSC Shipping & Transport Research
  • Olav Bakke
  • Petter Haugen
ABGSC Shipping & Transport Research ... (+3)
  • ABGSC Shipping & Transport Research
  • Olav Bakke
  • Petter Haugen
 PRESS RELEASE

Stolt-Nielsen Limited Reports Unaudited Results For the Third Quarter ...

Stolt-Nielsen Limited Reports Unaudited Results For the Third Quarter and Nine Months of 2025 Continued resilient performance in an uncertain environment LONDON, October 02, 2025 – Stolt-Nielsen Limited (Oslo Børs ticker: SNI) today reported unaudited results for the third quarter and the nine months ending August 31, 2025. The Company reported a third-quarter net profit of $64.0 million with revenue of $699.9 million, compared with a net profit of $99.2 million with revenue of $732.8 million in the third quarter of 2024. The net profit for the first nine months of 2025 was $290.6 million ...

ABGSC Shipping & Transport Research ... (+3)
  • ABGSC Shipping & Transport Research
  • Olav Bakke
  • Petter Haugen

ResearchPool Subscriptions

Get the most out of your insights

Get in touch